Different measures of HMGB1 location in cancer immunology
| dc.contributor.author | Gorgulho, Carolina Mendonca [UNESP] | |
| dc.contributor.author | Murthy, Pranav | |
| dc.contributor.author | Liotta, Lance | |
| dc.contributor.author | Espina, Virginia | |
| dc.contributor.author | Lotze, Michael T. | |
| dc.contributor.author | Galluzzi, L. | |
| dc.contributor.author | Rudqvist, N. P. | |
| dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
| dc.contributor.institution | Univ Pittsburgh | |
| dc.contributor.institution | George Mason Univ | |
| dc.date.accessioned | 2020-12-10T20:01:51Z | |
| dc.date.available | 2020-12-10T20:01:51Z | |
| dc.date.issued | 2019-01-01 | |
| dc.description.abstract | HMGB1 is the most abundant non-histone nuclear protein. It regulates transcriptional access to open areas of chromatin and limits release of DNA with apoptotic death, serving to both inhibit apoptosis and promote DNA repair. When HMGB1 is translocated to the cytosol with many types of cellular stress, it is a powerful inducer of autophagy. It can also be released by activated immune cells and damaged or dying cells into the extracellular space, where it acts as a damage associated molecular pattern (DAMP) molecule, contributing to the pathogenesis and progression of cancer. Here, the most common methodologies to not only measure HMGB1 but also to effectively determine its subcellular localization, which dictates many of HMGB1's different functions, are reviewed. | en |
| dc.description.affiliation | Sao Paulo State Univ, Botucatu Inst Biosci, Dept Microbiol & Immunol, Tumor Immunol Lab, Botucatu, SP, Brazil | |
| dc.description.affiliation | Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA | |
| dc.description.affiliation | George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA | |
| dc.description.affiliation | Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA | |
| dc.description.affiliation | Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA | |
| dc.description.affiliationUnesp | Sao Paulo State Univ, Botucatu Inst Biosci, Dept Microbiol & Immunol, Tumor Immunol Lab, Botucatu, SP, Brazil | |
| dc.format.extent | 195-217 | |
| dc.identifier | http://dx.doi.org/10.1016/bs.mie.2019.10.011 | |
| dc.identifier.citation | Tumor Immunology And Immunotherapy - Molecular Methods. London: Academic Press Ltd-elsevier Science Ltd, v. 629, p. 195-217, 2019. | |
| dc.identifier.doi | 10.1016/bs.mie.2019.10.011 | |
| dc.identifier.issn | 0076-6879 | |
| dc.identifier.uri | http://hdl.handle.net/11449/196964 | |
| dc.identifier.wos | WOS:000539028200012 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier B.V. | |
| dc.relation.ispartof | Tumor Immunology And Immunotherapy - Molecular Methods | |
| dc.source | Web of Science | |
| dc.title | Different measures of HMGB1 location in cancer immunology | en |
| dc.type | Resenha | pt |
| dcterms.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
| dcterms.rightsHolder | Elsevier B.V. | |
| dspace.entity.type | Publication | |
| relation.isOrgUnitOfPublication | ab63624f-c491-4ac7-bd2c-767f17ac838d | |
| relation.isOrgUnitOfPublication.latestForDiscovery | ab63624f-c491-4ac7-bd2c-767f17ac838d | |
| unesp.author.orcid | 0000-0001-6569-8647[1] | |
| unesp.campus | Universidade Estadual Paulista (UNESP), Instituto de Biociências, Botucatu | pt |
| unesp.department | Microbiologia e Imunologia - IBB | pt |

